Reaction
Mycotic Endophthalmitis reporting signals
As of the last recalculation, Mycotic Endophthalmitis appears in 186 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is MICAFUNGIN SODIUM (PRR 312.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Micafungin Sodium | 21 | 312.3 | 313.1 |
| Voriconazole Injection | 43 | 287.9 | 288.5 |
| Voriconazole | 47 | 231.4 | 231.7 |
| Terbinafine Hydrochloride | 15 | 205.4 | 205.8 |
| Basiliximab | 17 | 177.9 | 178.2 |
| Itraconazole | 13 | 133.8 | 134.0 |
| Posaconazole Delayed-Release | 12 | 130.6 | 130.8 |
| Amphotericin B | 13 | 124.8 | 124.9 |
| Posaconazole | 12 | 88.3 | 88.3 |
| Valganciclovir Hydrochloride Powder, | 9 | 86.7 | 86.8 |
| Remdesivir | 8 | 70.1 | 70.2 |